991 Final Results of the Ideal (individualized Dosing Efficacy Versus Flat Dosing to Assess Optimal Pegylated Interferon Therapy) Phase Iiib Study
Year: 2008
Type: article
Study design: Clinical Trial
Source: Journal of Hepatology
Institutions: Johns Hopkins University, Johns Hopkins Medicine, University of Florida, Ospedale Antonio Cardarelli, Scripps Clinic, Gastroenterology Hospital "Saverio de Bellis", University of Miami, Bach & Godofsky Infectious Diseases, Virginia Commonwealth University Medical Center, Duke University, Kelsey Research Foundation, University of North Carolina at Chapel Hill, Kaiser Permanente, Kaiser Permanente San Diego Medical Center, Methodist Dallas Medical Center, Brooke Army Medical Center, The University of Texas Southwestern Medical Center, Saint Louis University
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2005740971